Guardant Health (GH) Stock News
$GH · NASDAQ · 3 stories in 30 daysBORSA has published 3 stories on Guardant Health (GH) in the past 30 days. BORSA’s news read on GH is bullish at 65/100, −1 over 24 hours, based on 2 company events over the past 7 days. GH last closed at $165.88 on Oct 15, up 0.19% over five sessions and down 5.16% over the past month. Guardant Health’s next earnings report is scheduled for Wednesday, Nov 4.
The wire on $GH
newest first · updated · direct subject stories onlyGuardant Health presented new data at ACG 2026. A modeling study projected Shield blood test averted 12 CRC deaths per 1,000 individuals vs 6 for FIT and 9 for mt-sDNA. Real-world adherence in rural South Carolina clinics reached 99%, well above average CRC screening rates. The company says blood-based testing increases colonoscopy volume by bringing more patients into the screening pathway.
bullish 70 · impact 40